tirzepatide surmount-1 nejm 2022 weight loss percent Tirzepatide: In the trial, reduction percentages were dose-dependent: 5 mg: ~15.0% weight reduction. 10 mg: ~19.5% weight reduction. 15 mg: ~20.9% weight reduction (Jastreboff et al., 2022). https://www.nejm.org/doi/10.1056 GLP-1R Agonists for Weight Loss
Description
GLP1 receptor agonist liraglutide is an effective therapeutic option for perioperative glycemic control in type 2 diabetes within Enhanced Recovery after Surgery (ERAS) protocols

Beyond the physical, weight challenges often impact emotional well-being, leading to decreased self-esteem and social withdrawal

Short answer: no

This dual action suppresses appetite, slows gastric emptying, improves insulin sensitivity, and influences how your brain processes hunger and satiety signals

Women who take birth control pills should switch to barrier methods
